Maitri Porecha

India: Despite free care, TB takes a toll of patients’ finances

One in four patients affected by Tuberculosis (TB) has to spend out of his/her own pocket to access treatment, which should otherwise be anyway available for free.

Read More →

India: Delamanid to be available across the country

Crucial anti-Tuberculosis (TB) drug Delamanid will now be available across India. Until currently, its supply was restricted to seven States.

Read More →

India: Lack of digital ECGs slows roll-out of anti-TB drug

The roll-out of crucial anti-tuberculosis drug, Bedaquiline is slow because of a substantial lack of digital electrocardiogram (ECG) machines on field.

Read More →

India: 400 MDR-TB patients in 7 states to get crucial drug

India gets doses of Delamanid from USAID.

Read More →

India: Why TB, HIV control programs may not be combined

New Delhi, September 16 - The Centre’s long-pending plan to combine tuberculosis (TB) and human immunodeficiency virus (HIV) control programmes may never happen.

Read More →

TB eradication by 2025 unrealistic, says ICMR's Dr Soumya Swaminathan

Dr Soumya Swaminathan, Secretary of the Department of Health Research in India’s Ministry of Health & Family Welfare and Director General of the Indian Council of Medical Research (ICMR), speaks to DNA on ICMR’s ongoing study on cellphone tower radiation, dedication to eliminate leprosy and its future plans.

Read More →

TB drug affects vision in some patients

A study, jointly conducted by Medecins Sans Frontiers (MSF) and Lilavati Hospital in Mumbai, has shown that some anti-tuberculosis drugs can have adverse effects on the eye, and can even lead to compromised vision in patients.

Read More →

Mario Raviglione: Put in more money to tackle tuberculosis

Interview with Dr Mario Raviglione, Director, World Health Organization's Global Tuberculosis Programme since 2003. Dr Raviglione has worked on TB control issues for two decades. In conversation with Maitri Porecha at the 44th Union World Conference of Lung Health in Paris, France, Dr Raviglione talks about challenges India faces in tackling the dreaded Tuberculosis scourge.

Read More →

No let up in tuberculosis scourge, but funding dips

The scourge of tuberculosis (TB) continues to take thousands of lives every day across the world.

Read More →

Paris health meet shames India on TB drugs shortage

International activists jeered at Indian officials during the 44th Union World Conference on Lung Health in Paris, France over the unavailability and substandard supply of tuberculosis drugs in India. Tuberculosis kills about a thousand people in the country every day.

Read More →

Page 1 of 1 · Total posts: 10

1